In other words, today's leading blood test catches about 1 in 6 Stage I cancers; Dognosis catches 9 in 10. Galleri is a little more specific (fewer false positives) but Dognosis is meant to be radically cheaper, which is important in places like India where 80% of cancers are caught at Stage III or IV and roughly 1% of the population has ever been screened, and which is important to get more early screening generally.
